Drug News
-
Novo Nordisk, Eli Lilly, Boehringer Ingelheim Support Medicare Obesity Drug Coverage
Despite the considerable excitement surrounding new and potent obesity medications, the high costs associated with these drugs have made them…
Read More » -
Nurse Practitioners with Doctorates Challenge California Law on Title Usage
Three California nurse practitioners, all holding Doctor of Nursing Practice (DNP) degrees, have filed a lawsuit against the state of…
Read More » -
FDA Grants Approval to Vanflyta (Quizartinib) for Acute Myeloid Leukemia with Positive Results
On the 20th of July, 2023, Daiichi Sankyo (TSE: 4568) announced that Vanflyta (quizartinib) has been approved by the U.S. Food and…
Read More » -
Pfizer’s Plant Destroyed By EF-3 Tornado Was Making 25% of Injectables Used by Hospitals
On July 19, a monstrous EF-3 tornado ripped through Rocky Mount, North Carolina, leaving behind a path of destruction. Among…
Read More » -
European Medicines Agency Rejects Ipsen’s Palovarotene
Ipsen’s journey with palovarotene, a proposed treatment for the ultra-rare disease fibrodysplasia ossificans progressiva (FOP), has encountered another setback with…
Read More » -
Automated Insulin Delivery System, Not an Artificial Pancreas – Anne Louise Peters (MD)
This transcript has been edited for clarity. I’d like to clear up the confusion about whether or not there is…
Read More » -
The Intriguing Link Between Chronic Constipation and Cognitive Decline
Chronic constipation has long been regarded as a gastrointestinal issue, but recent preliminary research suggests that its implications may extend…
Read More » -
FDA and ASHP List 9 New Drugs Facing Critical Shortages
The U.S. FDA and the American Society of Health-System Pharmacists (ASHP) recently made an alarming announcement, adding nine drugs to…
Read More » -
New Research Reveals Alarming Risks of Opioid Use in Elderly Patients with Dementia
A groundbreaking study conducted in Denmark has uncovered concerning evidence regarding opioid painkiller usage in elderly individuals diagnosed with dementia.…
Read More » -
Johnson & Johnson Joins Merck and Others In Suit Against IRA’s Drug Price Negotiations
Johnson & Johnson, a prominent pharmaceutical company, has joined the ranks of drugmakers suing the U.S. government over drug price…
Read More »